Revive Therapeutics Ltd (OTCMKTS: RVVTF) has provided an update on the US FDA Phase 3 clinical study evaluating Bucillamine’s efficacy and safety in patients having Mild to moderate COVID-19.
DSMB approved the continuation of the study
The clinical trial is a double-blinded, placebo-controlled, randomized trial, with the safety and efficacy data at every preliminary analysis time point, and the final interim analysis at 800 completed patients is only made available to the Independent Data and Safety Monitoring Board (DSMB) for review.
The DSMB approved the study’s continuation at its most recent meeting because no significant adverse events or safety concerns had been recorded. The final interim analysis meeting is scheduled for Q4-2021.
A recent study on Thiol-based medications established that such drugs like Bucillamine could minimize SARS CoV-2 spike protein’s binding to receptors, minimize entry efficiency of the SARS CoV-2 spike pseudotyped virus and inhibit infection of SARS CoV-2 virus. Revive therapeutics supported the study under the sponsored agreement with the University of California San Francisco.
Bucillamine can potentially treat mild-to-moderate COVID-19.
CEO Michael Frank commented, “As we move forward in our Phase 3 study in COVID-19 with the aim to seek EUA approval from the FDA for Bucillamine in the treatment of mild to moderate COVID-19, we are also cognizant of the rapidly changing landscape of COVID-19 specifically with the Delta variant becoming widespread. The incorporation of adding viral load testing to patients in the Study, along with our support in the research of the potential utility of thiol-based drugs, like Bucillamine, in the Delta variant of COVID-19, shows our confidence in Bucillamine’s potential as a safe and effective oral treatment for mild to moderate COVID-19.”
Frank added, “We recognize the market opportunity for Bucillamine and we are in discussions with our manufacturing partners to ensure that billions of Bucillamine tablets can be made available in 2022 to support our future commercialization partners and the millions of people globally.”
Isracann Biosciences Inc. (OTCMKTS: ISCNF) and Auxly Cannabis Group Inc. (OTCMKTS: CBWTF) Announce Executive Leadership Appointment
Isracann Biosciences Inc. (OTCMKTS: ISCNF) appointed Mr. Phil Floucault as its Chief Executive Officer effective October 20, 2021.
Isracann appoints new CEO
Most recently, Floucault served as CEO, President, and Co-founder of Costa Canna Group & United Greeneries Ltd. that in turn served Canadian retail stores, processing, federal production, local and international sales, and distribution, as well as product development in the cannabis sector.
Floucault will replace Darryl Jones, who resigned as CEO but will continue serving in the capacity of a board director. The company acknowledged that as it transitions from the developmental phase into an operating entity, it is ideal for making proactive senior management changes leveraging industry experience to optimize opportunities.
Floucault stated, “I am delighted to have this opportunity to serve with this highly motivated and experienced team as we push ahead in the Israeli marketplace. We have numerous elements rapidly coming together and are incredibly optimistic about the domestic opportunity and future access into the European markets. The future looks excellent, and we are ready to hit the ground running.”
Auxly appoint Murray McGowan to its Board
Auxly Cannabis Group Inc. (OTCMKTS: CBWTF) has appointed Imperial Brands Plc Chief Strategy and Development Officer, Murray McGowan, to its Board effective November 1, 2021.
Genevieve Young, Auxly Board of Directors Chair, said, “We are excited to welcome Murray to our board during an important stage in Auxly’s growth. Murray’s extensive strategy and development experience will be invaluable to the company as it continues to grow into one of the leading licensed producers in the country. We are also thrilled that Conrad has decided to remain on Auxly’s Board after his departure from Imperial as it provides an important piece of continuity. His experience and expertise has been incredibly valuable over the course of the last two years and we are delighted to be able to retain the benefit of his counsel, insight and support on our Board of Directors.”
Priority Aviation Inc. (OTCMKTS: PJET) Agrees To Fund And Construct Student Housing Project Supporting a Private University
Priority Aviation Inc. (OTCMKTS: PJET) has agreed on terms to fund and construct a student housing and residential building in Texas supporting a small private institution whose enrolment is around 1200 students.
Priority Aviation shifted its business strategy
Recently the company announced a shift in business strategy, with Priority Aviation now focusing on the student housing industry. A software application set to launch in early December is at the heart of the company’s business plan. The company plans to launch the Student Housing Application in early December.
Currently, student housing is in short supply, and just about 22% of students live on campus. PJET expects its Student Housing App to be well received by the resource-strapped student housing market.
PJET intends to focus on smaller, underrepresented colleges. Notably, the physical housing project unveiled is the first of its kind to complement the Student Housing App initiative, which is aimed at supporting smaller universities.
Besides being an App that aims to be the Airbnb of student housing, the App is designed to maximize advertising to university students.
US students have the spending power of $376 billion
Over $376B in spending power is projected to be held by 21 million college students in the United States. For instance, last year, students spent $39 billion on food alone. The annual cost of clothing and accessories for students is projected to be $67 billion. Universities spend about $1 billion a year on advertising to the university student group.
While transaction income from the Student Housing App is expected to be significant, PJET anticipates that advertising to the university student population via high-margin advertising revenue will be the key profit source.
The architecture of PJET’s Student Housing App contains an artificial intelligence engine that maximizes the App’s usefulness to businesses seeking to attract university students. The company redirected its operations at the beginning of this year with a focus on student housing.
Trulieve Cannabis Corp (OTCMKTS: TCNNF) Completes Rebranding Of Former Harvest House of Cannabis Stores in Florida
Trulieve Cannabis Corp (OTCMKTS: TCNNF) has completed the conversion of all Florida locations formerly branded Harvest House of Cannabis with the reopening of the Port St. Lucie, Florida dispensary. The 107th Trulieve dispensary in Florida started serving patients on Friday, October 2021.
Trulieve acquired Harvest Health and Recreation
The reopening comes after the company’s acquisition of Harvest Health and Recreation Inc. on October 1. It’s the 14th and last makeover of a former Harvest House of Cannabis dispensary in Florida.
The community of Port St. Lucie is invited to celebrate the launch of this dispensary with Trulieve. On opening day, there will be complimentary food from the local Bagel Boyz food truck, music, all-day bargains, and partner swag giveaways from retailers like Sunshine Cannabis. Also, once the new Port St. Lucie facility opens, all patients will be eligible for a 25% in-store discount, and first-time Trulieve clients will be given a 50% new customer discount, as usual at the Port St. Lucie and other dispensaries across the state.
Customers can order online or instore pickup
Trulieve CEO Kim Rivers said, “With every location Trulieve opens, we are delivering on our commitment to provide Florida’s patients with safe and reliable access to the cannabis products they rely on. We are thrilled to complete the Florida store conversions and look forward to serving patients in every corner of the state as we continue to introduce legacy Harvest brands and welcome customers with an unrivaled retail experience.”
Patients will find the largest assortment of THC and CBD products in Florida, including edibles, concentrates, smokable flower, tinctures, vaporizers, topical creams, and more, in stores and online. Trulieve also provides home delivery throughout the state, as well as convenient online ordering and in-store pickup. The company currently operates in 11 states with lead positions in Florida, Arizona, and Pennsylvania and will continue its accelerated expansion and retails and distribution growth.